<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

Orthotopic, Bioluminescent Syngeneic HCC Models for Immunotherapy Assessment

There are currently limited treatment options for hepatocellular carcinoma (HCC), which is a highly aggressive cancer type. While immunotherapies such as checkpoint inhibitors are being trialled clinically, suitable preclinical models are needed to optimise and speed their development.